Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Imunon (IMNN) Q3 2026 Earnings Call Transcript

Enrollment is ahead of plan in its pivotal ovarian cancer trial as cash tightens.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at fool.com →

More in Finance & Markets

More from Thursday 12 November →